Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2016-06-27 Regulatory Filings
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Communiqué de presse
Regulatory Filings Classification · 95% confidence The document is a press release from Global Bioenergies announcing the delivery of isobutene samples to Clariant for testing. It details a business development milestone, mentions other industrial partners, and provides company background. This type of announcement, which is not a formal regulatory filing (like 10-K, IR, or ER) but rather a specific business update or partnership news, fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, as there is no specific category for 'Business Partnership Announcement' or 'Press Release'. Given the short length (2750 chars) and the nature of the content (announcing an event/delivery), it is not a comprehensive report, but a direct communication. RNS is the most appropriate fallback.
2016-06-27 French
PRESS RELEASE
Environmental & Social Information Classification · 99% confidence The document is a press release dated June 13, 2016, announcing a technical achievement regarding the compatibility of bio-sourced isobutene with chemical oxidation, resulting in methacrylic acid. It details project milestones (BIOMA+), partnerships (Arkema), and quotes management. This type of announcement, focusing on operational or technical progress rather than formal financial results (like 10-K or ER) or shareholder actions, fits best under a general regulatory announcement or news release category. Since it is not a formal financial report, a proxy statement, or a specific management/board change, the most appropriate classification is Regulatory Filings (RNS), which serves as a general category for significant corporate news releases that don't fit elsewhere. The document length (4281 chars) is substantial enough to be the primary announcement itself, not just a brief notice of publication.
2016-06-13 English
COMMUNIQUE DE PRESSE
Regulatory Filings Classification · 95% confidence The document is a press release dated June 13, 2016, announcing the successful finalization of tests regarding the chemical oxidation of bio-sourced isobutene, a key component for producing methacrylic acid. It details technical validation achieved with a partner (Arkema) and mentions project funding (BIOMA+ project supported by ADEME). This content is characteristic of an announcement detailing a significant operational or technical milestone, often released to the public and investors. It is not a formal regulatory filing like a 10-K, a quarterly report (IR), or a formal earnings release (ER). Since it is a specific announcement about a technical achievement and partnership validation, it fits best under the general category of Regulatory Filings (RNS) as a miscellaneous corporate announcement, or potentially an Investor Presentation (IP) if it were a slide deck, but given the format, RNS is the most appropriate general category for non-standard, material news releases that aren't explicitly covered by other codes like DIV, CAP, or MANG. Given the options, and that it's a news announcement, RNS is the best fit as a general regulatory/corporate update.
2016-06-13 French
COMMUNIQUE DE PRESSE
Regulatory Filings Classification · 95% confidence The document is a press release dated June 8, 2016, announcing the receipt of the final major equipment for the Leuna demonstrator plant. It details project progress, quotes management, and provides general company information. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is an announcement regarding operational progress and technology development. Since it doesn't fit the specific categories like M&A (TAR), Financing (CAP), or Director Dealing (DIRS), and it is a general update/announcement, it falls best under the general Regulatory Filings/Announcements category (RNS), as it is an official communication to the market about a significant operational milestone, often disseminated via regulatory channels when no other specific category applies. Given the short length (3170 chars) and the nature of the announcement (updating on a project milestone), it is a general corporate communication.
2016-06-08 French
PRESS RELEASE
Regulatory Filings Classification · 95% confidence The document is a press release dated June 8, 2016, announcing a specific operational milestone: the receipt of the last major equipment unit (the purification skid) for the Leuna demo plant. It discusses construction progress, commissioning timelines, and the purpose of the plant. This type of operational update, which is not a formal financial report (like 10-K or IR), management discussion (MDA), or earnings release (ER), fits best under general regulatory announcements or news releases that don't have a more specific category. Since it is a general operational update and not a formal filing like a Director's Dealing (DIRS) or Capital Change (CAP), the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general corporate announcement to the market.
2016-06-08 English
Communiqué de Presse
Capital/Financing Update Classification · 98% confidence The document announces that the French 'Investissements d'Avenir' program is granting 9 million euros in financing to Global Bioenergies and IBN-One for a project involving Cristal Union and L'Oréal, focused on building the first biological isobutene production plant. This announcement details a specific financing event, project milestones, and collaboration between companies regarding capital/funding for a strategic industrial project. This fits best under 'Capital/Financing Update' (CAP), as it is a direct announcement of receiving significant funding for development, rather than a general earnings release (ER) or a comprehensive quarterly report (IR). It is not a formal regulatory filing like a 10-K or a proxy statement.
2016-06-06 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.